Novartis US President Thomas Kendris, Amgen CEO Robert Bradway, and Mallinckrodt CEO Mark Trudeau didn't sit at the witness table but testified remotely during the US House Oversight Committee's second day of hearings on Rx pricing on 1 October 2020. • Source: photo illustration from committee feed and company photos
